TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP. Share Price

Certificat

DE000SB07416

Market Closed - Boerse Frankfurt Warrants 20:45:59 26/04/2024 BST
13.58 EUR -0.66% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP.
Current month-9.80%
1 month-6.79%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
26/04/24 13.72 +0.37% 0
25/04/24 13.67 -0.22% 0
24/04/24 13.7 +2.01% 0
23/04/24 13.43 +4.60% 0
22/04/24 12.84 +1.50% 0

Real-time Boerse Frankfurt Warrants

Last update April 26, 2024 at 08:45 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SB0741
ISINDE000SB07416
Date issued 09/06/2020
Strike 191.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.98
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.71
Lowest since issue 2.04

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
335.6 USD
Average target price
365.7 USD
Spread / Average Target
+8.96%
Consensus